Metabolic syndrome, a concurrence of disorders including obesity, impaired fasting glucose and/or impaired glucose tolerance, reduced insulin sensitivity, hyperinsulinemia, dyslipidemia, and hypertension has gained importance because of its association with the subsequent development of T2D and its complications (Fujimoto 2000). Here, INS is linked to hypertensive disorder.